BioSig Technologies, Inc.
BSGM
$6.39
-$0.52-7.53%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | 13.00K | -- | 13.00K | 14.00K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | 13.00K | -- | 13.00K | 14.00K |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | 13.00K | -- | 13.00K | 14.00K |
SG&A Expenses | 2.96M | 1.07M | 2.76M | 4.91M | 2.88M |
Depreciation & Amortization | 21.00K | 30.00K | 31.00K | 49.00K | 78.00K |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 2.98M | 1.20M | 2.95M | 5.31M | 3.20M |
Operating Income | -2.98M | -1.18M | -2.95M | -5.29M | -3.18M |
Income Before Tax | -2.80M | -1.10M | -1.91M | -3.91M | -3.42M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -2.80M | -1.10M | -1.91M | -3.91M | -3.42M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -12.00K | 0.00 | -- | -4.00K | 13.00K |
Net Income | -2.81M | -1.10M | -1.91M | -3.92M | -3.40M |
EBIT | -2.98M | -1.18M | -2.95M | -5.29M | -3.18M |
EBITDA | -2.96M | -1.15M | -2.92M | -5.24M | -3.11M |
EPS Basic | -0.14 | -0.07 | -0.12 | -0.30 | -0.36 |
Normalized Basic EPS | -0.09 | -0.04 | -0.11 | -0.26 | -0.20 |
EPS Diluted | -0.14 | -0.07 | -0.12 | -0.30 | -0.36 |
Normalized Diluted EPS | -0.09 | -0.04 | -0.11 | -0.26 | -0.20 |
Average Basic Shares Outstanding | 20.79M | 17.16M | 16.20M | 12.92M | 9.86M |
Average Diluted Shares Outstanding | 20.79M | 17.16M | 16.20M | 12.92M | 9.86M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |